Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 1,435,000 4.800% |
-115,000 (-7.42%) |
Filing History |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,264,801 7.600% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,264,801 7.600% |
100,000 (+4.62%) |
Filing History |
| 2023-02-14 08:31 am Purchase |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 2,819,045 9.500% |
1,322,907 (+88.42%) |
Filing History |
| 2023-02-10 10:04 am Sale |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
JANUS HENDERSON GROUP PLC JHG |
1,503,447 5.100% |
-191,962 (-11.32%) |
Filing History |
| 2022-05-02 4:02 pm Purchase |
2022-04-20 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 1,550,000 5.200% |
680,000 (+78.16%) |
Filing History |
| 2022-03-14 09:29 am Sale |
2022-03-08 | 13D | Bicycle Therapeutics plc BCYC |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.800% |
-549,702 (-28.08%) |
Filing History |
| 2022-02-14 4:40 pm Purchase |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 1,572,823 5.300% |
135,247 (+9.41%) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 2,164,801 7.400% |
302,968 (+16.27%) |
Filing History |
| 2022-02-14 3:16 pm Sale |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 870,000 3.000% |
-630,000 (-42.00%) |
Filing History |
| 2022-02-11 4:32 pm Sale |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Novartis Bioventures Ltd | 673,360 2.290% |
-967,786 (-58.97%) |
Filing History |
| 2022-02-11 1:58 pm Purchase |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
JANUS HENDERSON GROUP PLC JHG |
1,695,409 5.800% |
1,695,409 (New Position) |
Filing History |
| 2022-01-27 4:35 pm Purchase |
2022-01-24 | 13G | Bicycle Therapeutics plc BCYC |
Deep Track Capital, LP | 1,496,138 5.090% |
1,496,138 (New Position) |
Filing History |
| 2021-09-16 5:22 pm Sale |
2021-08-05 | 13D | Bicycle Therapeutics plc BCYC |
GLAXOSMITHKLINE PLC | 1,529,561 6.000% |
-86,734 (-5.37%) |
Filing History |
| 2021-08-16 11:19 am Sale |
2021-07-21 | 13D | Bicycle Therapeutics plc BCYC |
SVLSF V LLC | 1,562,451 6.490% |
-352,823 (-18.42%) |
Filing History |
| 2021-07-28 7:32 pm Purchase |
2021-07-19 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 1,500,000 6.200% |
1,500,000 (New Position) |
Filing History |
| 2021-04-16 4:17 pm Sale |
2021-04-09 | 13D | Bicycle Therapeutics plc BCYC |
GLAXOSMITHKLINE PLC | 1,616,295 7.000% |
-278,536 (-14.70%) |
Filing History |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Ridgeback Capital Investments L.P. | 1,861,833 8.700% |
717,200 (+62.66%) |
Filing History |
| 2021-02-16 3:25 pm Purchase |
2020-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 1,437,576 6.700% |
334,600 (+30.34%) |
Filing History |
| 2021-02-02 1:00 pm Sale |
2020-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Atlas Venture Fund VIII L.P. | 612,696 2.880% |
-750,000 (-55.04%) |
Filing History |